{
    "EU-1-21-1541_h_dec_0.pdf": {
        "file_link": "https://ec.europa.eu/health/documents/community-register/2022/20220324154987/dec_154987_en.pdf",
        "file_date": "2022-03-24 00:00:00",
        "medicine_updated": "2022-11-25 21:50:26.635312"
    },
    "EU-1-21-1541_h_anx_0.pdf": {
        "file_link": "https://ec.europa.eu/health/documents/community-register/2022/20220324154987/anx_154987_en.pdf",
        "file_date": "2022-03-24 00:00:00",
        "medicine_updated": "2022-11-25 21:50:26.811478"
    },
    "EU-1-21-1541_h_public-assessment-report.pdf": {
        "file_link": "https://www.ema.europa.eu/documents/assessment-report/dasatinib-accordpharma-epar-public-assessment-report_en.pdf",
        "file_date": "2022-11-25 21:50:26.812527",
        "medicine_updated": "2022-11-25 21:50:26.812527"
    }
}